Founded in 2017 by Bill Maris, Section 32 has raised $150 million to invest in a range of sectors, including healthcare, biotechnology, fintech, and artificial intelligence. The firm's focus is on improving the human condition by accelerating the discovery, development, adoption, and distribution of important technologies and life-saving medicines. Section 32 is based in Los Altos, California, but primarily operates out of San Diego, and is run directly by Bill Maris, with a team of managing partners, senior principals, and advisors.